<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03985514</url>
  </required_header>
  <id_info>
    <org_study_id>App 2018</org_study_id>
    <nct_id>NCT03985514</nct_id>
  </id_info>
  <brief_title>Acute Appendicitis: Active Observation With and Without Antibiotics</brief_title>
  <official_title>Optimized Treatment for Uncomplicated Acute Appendicitis; Active Observation With or Without Antibiotic Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if early provision of antibiotics is a superior treatment compared to&#xD;
      &quot;traditional wait and see&quot; with regard to symptom relief for suspected acute uncomplicated&#xD;
      appendicitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent long-term follow up results of antibiotic treatment of acute appendicitis in&#xD;
      unselected populations indicate that approximately 70-80 % of patients respond to&#xD;
      antibiotics, while the remaining 20-25% need an operation. Antibiotic treatment was&#xD;
      associated with significantly fewer severe and non-severe complications compared to surgery.&#xD;
      Therefore, antibiotic treatment can be regarded as safe and effective initial treatment of&#xD;
      acute appendicitis based on evidence.&#xD;
&#xD;
      However, it remains to be evaluated to what extent antibiotic treatment is more effective&#xD;
      compared to the most conservative application of procedures in the care of patients with&#xD;
      acute appendicitis. A well- recognized approach in Sweden is watchful waiting at in-hospital&#xD;
      conditions. A certain number of patients with suspected uncomplicated appendicitis will&#xD;
      likely recover without any active treatment, but controlled evidence are lacking to what&#xD;
      extent such recoveries may occur in the short- and long-term perspective.&#xD;
&#xD;
      The hypothesis is that antibiotic treatment is superior to active observation with regard to&#xD;
      symptom relief at suspected acute appendicitis in selected patient groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2018</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Selected patients with assumed uncomplicated acute appendicitis are allocated to groups &quot;Active observation&quot; or &quot;Antibiotic treatment&quot; in a 1:1 ratio.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with no symptom relief</measure>
    <time_frame>48 hours</time_frame>
    <description>No symptom relief and surgery is deemed necessary.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>Antibiotic treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive in-hospital intravenous antibiotics (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3). Surgery if no symptom relif occur.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical observation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are followed by in-hospital &quot;Active observation&quot; (watchful waiting) according to clinical routine. Patients are observed until either, recovery and dismissal from hospital, or decision for intervention (surgery) is taken.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic treatment (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3).</intervention_name>
    <description>Intravenous antibiotic treatment x 3, followed by oral antibiotics for 8-10 Days.</description>
    <arm_group_label>Antibiotic treatment</arm_group_label>
    <other_name>Piperacillin/Tazobactam</other_name>
    <other_name>Ciprofloxacin</other_name>
    <other_name>Flagyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active observation</intervention_name>
    <description>In-hospital observation without antibiotics</description>
    <arm_group_label>Clinical observation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects with suspected appendicitis.&#xD;
&#xD;
          -  Age&lt;60 years.&#xD;
&#xD;
          -  C-reactive protein &lt; 60 mg/L.&#xD;
&#xD;
          -  White blod cell Count (leucocytes) &lt; 13 e9 /L.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kent Lundholm, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lundholm</last_name>
    <phone>+46-313421000</phone>
    <phone_ext>4437</phone_ext>
    <email>kent.lundholm@surgery.gu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of surgery, Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Lundholm, MD, prof</last_name>
      <phone>46-31-342-1000</phone>
      <phone_ext>4437</phone_ext>
      <email>kent.lundholm@surgery.gu.se</email>
    </contact>
    <investigator>
      <last_name>Kent Lundholm, MD, prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2019</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Piperacillin, Tazobactam Drug Combination</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

